Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 1/20 | 0.53 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | PDE10A | Q9Y233 | 7/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | CFTR | P13569 | 1/20 | 0.49 |
| ▸ | MGAM | O43451 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30644247 | 0.86 | CYP1A2 (0.58) | PDGFRBPDGFRACYP1A2PDE10ARAB9A | |
| SCHEMBL1772519 | 0.86 | BIRC5 (0.47) | PDGFRBPDGFRACYP1A2PDE10AKDM1A | |
| SCHEMBL28532450 | 0.85 | PDGFRB (0.53) | PDGFRBPDGFRACYP1A2KDM1AMAOA | |
| SCHEMBL28050901 | 0.82 | CYP11B1 (0.46) | PDGFRBPDGFRACYP1A2PDE10A | |
| SCHEMBL27522816 | 0.82 | CYP1A2 (0.47) | PDGFRBPDGFRACYP1A2PDE10AKDM1A | |
| SCHEMBL3396692 | 0.82 | CYP1A2 (0.55) | PDGFRBPDGFRACYP1A2PDE10AKDM1A | |
| Ethylbenzene SCHEMBL28002148 | 0.81 | CYP1A2 (0.52) | PDGFRBPDGFRACYP1A2PDE10AKDM1A | |
| SCHEMBL6614214 | 0.81 | PDGFRB (0.50) | PDGFRBPDGFRACYP1A2PDE10AKDM1A | |
| SCHEMBL22926854 | 0.81 | PDE10A (0.49) | CYP1A2PDE10ARAB9ACALM1KDM4E | |
| SCHEMBL12277481 | 0.81 | HTT (0.41) | PDE10ACALM1KDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0957891-B1 | REDUCTION OF HAIR GROWTH | GILLETTE CO (US) | 2003-03-19 | — | — | EP | claimed |
| US-6037326-A | APPLYING TO THE SKIN AN INHIBITOR OF A DNA TOPOISOMERASE | GILLETTE COMPANY, THE | 2000-03-14 | — | — | US | claimed |
| EP-0957891-A1 | REDUCTION OF HAIR GROWTH | HANDELMAN, Joseph H. (US) | 1999-11-24 | — | — | EP | claimed |
| WO-1998029086-A1 | REDUCTION OF HAIR GROWTH | HANDELMAN, JOSEPH, H. (US) | 1998-07-09 | — | — | WO | claimed |
| US-20250367649-A1 | PHOTOCATALYSTS, PREPARATION AND USE THEREOF | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV (CA) | 2025-12-04 | — | — | US | disclosed |
| CN-120040301-A | Aromatic amine organic compound, mixture, composition and organic electronic device | 广州华睿光电材料有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-116354981-B | Organic compound, mixture, composition and organic electronic device comprising same | 广州华睿光电材料有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-116082266-B | Organic compounds, mixtures, compositions, light extraction layer materials and organic electronic devices | 广州华睿光电材料有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119504816-A | Organic compound containing boron-10 isotope and application thereof | 广州工程技术职业学院 | 2025-02-25 | — | — | CN | disclosed |
| CN-115894254-B | Organic compounds, mixtures, compositions and organic electronic devices | 广州华睿光电材料有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119343338-A | Aromatic amine organic compound and application thereof in organic electronic device | 浙江光昊光电科技有限公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-116178323-B | Aromatic amine organic compound, mixture, composition and organic electronic device | 广州华睿光电材料有限公司 | 2024-11-29 | — | — | CN | disclosed |
| US-20080227775-A1 | Quinoline Derivatives as Antibacterial Agents | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-09-18 | — | — | US | disclosed |
| US-7338949-B2 | Mycobacterial inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-03-04 | — | — | US | disclosed |
| US-20070093478-A1 | Novel mycobacterial inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-04-26 | — | — | US | disclosed |
| US-20070082895-A1 | Novel mycobacterial inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-04-12 | — | — | US | disclosed |
| EP-0957891-B1 | REDUCTION OF HAIR GROWTH | GILLETTE CO (US) | 2003-03-19 | — | — | EP | disclosed |
| US-6037326-A | APPLYING TO THE SKIN AN INHIBITOR OF A DNA TOPOISOMERASE | GILLETTE COMPANY, THE | 2000-03-14 | — | — | US | disclosed |
| EP-0957891-A1 | REDUCTION OF HAIR GROWTH | HANDELMAN, Joseph H. (US) | 1999-11-24 | — | — | EP | disclosed |
| WO-1998029086-A1 | REDUCTION OF HAIR GROWTH | HANDELMAN, JOSEPH, H. (US) | 1998-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227775-A1 | Quinoline Derivatives as Antibacterial Agents | NQO2, HRH1, HRH2 | PDGFRB 2400/4885PDGFRA 2270/4885CYP1A2 182/4885 |
| US-20070082895-A1 | Novel mycobacterial inhibitors | HRH4, NAT1, CBR3 | PDGFRB 1930/4885PDGFRA 2385/4885CYP1A2 478/4885 |
| US-20250367649-A1 | PHOTOCATALYSTS, PREPARATION AND USE THEREOF | PPOX, AOX1, CYP3A7 | PDGFRB 3230/4885PDGFRA 2798/4885CYP1A2 11/4885 |
| US-20070093478-A1 | Novel mycobacterial inhibitors | NQO2, NAT1, HRH1 | PDGFRB 3090/4885PDGFRA 3504/4885CYP1A2 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.